The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.85
Bid: 27.50
Ask: 28.20
Change: -0.75 (-2.62%)
Spread: 0.70 (2.545%)
Open: 28.75
High: 28.75
Low: 27.75
Prev. Close: 28.60
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - hVIVO plc

13 Dec 2019 09:23

RNS Number : 8089W
Numis Securities Limited
13 December 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

hVIVO plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Nominated Adviser to hVIVO plc

(d) Date dealing undertaken:

12/12/2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

None

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary 5p

Sale

17,632

11.9100 GBX

11.9100 GBX

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

13/12/2019

Contact name:

Naomi Brennan

Telephone number:

0207 260 1330

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREANADFAANFEF
Date   Source Headline
13th Apr 20157:00 amRNSChange of Name to hVIVO plc
8th Apr 20157:00 amRNSDirectors' Dealings
4th Mar 20157:00 amRNSNew Ordinary Shares
16th Feb 20157:00 amRNSTrading Update
9th Jan 20157:00 amRNSDirectors' Dealings
25th Nov 20142:30 pmRNSTrading Update
6th Nov 20147:00 amRNSDirector's Dealings
4th Nov 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSBoard Change
25th Sep 20147:00 amRNSHalf Yearly Report
5th Sep 20147:00 amRNSNotification of Major Interest in Shares
5th Sep 20147:00 amRNSNotification of Major Interest in Shares
4th Sep 20147:00 amRNSNotification of Major Interest in Shares
1st Sep 20142:05 pmRNSResult of General Meeting
26th Aug 20147:00 amRNSNotification of Major Interest in Shares
21st Aug 20147:00 amRNShVIVO HCM of GS-5806 in RSV for Gilead Sciences
14th Aug 20147:00 amRNSConditional Placing to raise £33.6 million
28th Jul 20147:00 amRNShVIVO HCM of AL-8176 in RSV for Alios BioPharma
14th Jul 20147:00 amRNSBoard Change
4th Jul 20147:00 amRNSNotification of Major Interest in Shares
26th Jun 20147:00 amRNSBoard Change
12th Jun 20147:00 amRNSBoard Changes
4th Jun 20147:00 amRNSStart of hVIVO Challenge Study in Asthma
2nd Jun 20147:00 amRNSInvestor Event
21st May 20144:00 pmRNSResult of AGM
12th May 20147:00 amRNSNotification of Major Interest in Shares
1st May 20147:00 amRNSNotification of Major Interest in Shares
17th Apr 20142:00 pmRNS2013 Annual Report and Accounts
9th Apr 20147:01 amRNSBoard Changes
9th Apr 20147:00 amRNSAudited 2013 Preliminary Results
20th Mar 20147:00 amRNSNotification of Major Interest in Shares
19th Mar 20147:03 amRNSNew state of the art biomedical facility in UK
4th Mar 20147:00 amRNSAcquisition
16th Dec 20137:00 amRNSTrading Update
26th Sep 20137:00 amRNSHalf Yearly Report
28th Aug 20137:00 amRNSContract Win
23rd Aug 20137:00 amRNSContract Win
5th Jul 20137:00 amRNSNotification of Major Interest in Shares
5th Jul 20137:00 amRNSNotification of Major Interest in Shares
5th Jul 20137:00 amRNSNotification of Major Interest in Shares
5th Jul 20137:00 amRNSNotification of Major Interest in Shares
2nd Jul 20131:22 pmRNSResult of General Meeting
2nd Jul 20137:00 amRNSNotification of Major Interest in Shares
1st Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSNotification of Major Interest in Shares
26th Jun 20137:00 amRNSNotification of Major Interest in Shares
14th Jun 20137:00 amRNSConditional Placing to raise £25.5 million
23rd May 20137:00 amRNSResult of AGM
19th Apr 201312:00 pmRNS2012 Annual Report and Accounts
10th Apr 20137:00 amRNSAudited 2012 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.